George Yancopoulos, President and Chief Scientific at REGENERON PHARMACEUTICALS, INC. (REGN), sold 99,227 shares at $626.10 ($62.0M) on 2021-08-16, disclosed to the SEC on 2021-08-17.
Open-market sale of $62.0M REGN by President and Chief Scientific. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $625.00 | 773 | $483K | 0.8% |
| 2 | $625.25 | 46,925 | $29.3M | 47.3% |
| 3 | $625.25 | 46,925 | $29.3M | 47.3% |
| 4 | $626.10 | 2,302 | $1.4M | 2.3% |
| 5 | $626.10 | 2,302 | $1.4M | 2.3% |
| Total | $625.29 avg | 99,227 |
| $62.0M |
| 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |